More women with breast cancer are opting for mastectomy rather than undergoing breast conservation surgery.
Women who take calcium channel blockers to treat their hypertension are not at increased risk for developing breast cancer.
Partial breast irradiation (APBI) with proton therapy, as opposed to whole breast irradiation (WBI), may prove more affordable and have a more beneficial length of treatment for patients with early stage breast cancer.
SERMs and aromatase inhibitors have been proven to be excellent agents in the preventive setting for ER-positive breast cancer, but newer agents must be found specifically for ER-negative breast cancers, which mostly occur in premenopausal women.
Researchers have demonstrated that employing mindfulness meditation or being a member of a support group has a positive physical impact at the cellular level in breast cancer survivors.
Newly developed software enables genetic mutation analysis of breast cancer tumors, allowing for greater accuracy.
The addition of tomosynthesis to biennial digital mammography screening for women with dense breasts should improve breast cancer detection at a reasonable cost.
What are the treatment options for recurrent metastatic HER2-positive breast cancer after trastuzumab therapy?
The Society for Integrative Oncology (SIO) and co-researchers issue a report card on complementary therapies for breast cancer
A majority of breast cancer patients in the U.S. use complementary therapies after a breast cancer diagnosis, but there has been little science-based guidance about their safety and effectiveness.
Patients of Mexican descent with breast cancer and family history of breast or ovarian cancer were nearly two times as likely to have triple negative breast cancer.
Diffuse optical spectroscopic tomographic imaging (DOST) may be useful in predicting which patients will best respond to chemotherapy used to reduce breast cancer tumors before surgery, according to a new study.
Latina patients with breast cancer had much more awareness of clinical trials versus women who received the typical information.
People who are lactose intolerant have a decreased risk for developing breast, lung, and ovarian cancers.
The addition of trastuzumab to chemotherapy significantly improved the overall and disease-free survival of women with early stage HER2-positive breast cancer.
Tai chi may reduce the risk of breast cancer recurrence by decreasing inflammation in patients who have had breast cancer.
Women with breast cancer are at an increased long-term risk for developing first depression.
Location of a breast cancer tumor, on the left or right side, does not impact overall survival in patients treated with breast-conserving surgery and adjuvant external beam radiation therapy.
Cancer stage may play a role in the decision to undergo mastectomy rather than lumpectomy for women with early stage breast cancer, according to recent research.
Researchers identified the benefits of exercise therapy and electro-acupuncture in breast cancer survivors.
For black women and Hispanic women, obesity increases postmenopausal risk of estrogen receptor (ER)-negative and progesterone receptor-positive breast cancer.
Mindfulness mediation has effects on the cellular level of the body of breast cancer survivors.
As cancer care evolves toward anticipatory rather than reactionary care, oncology nurses should consider developing important new skills.
Hot flashes experienced by women who have been treated for breast cancer are not being sufficiently addressed by clinicians.
A federal prescription-subsidy program for low-income Medicare recipients has increased adherence to hormone therapy to prevent breast cancer recurrence after surgery, according to recent data.
Cost is a key factor for women to maintain their hormone treatment regimen, researchers report.
The combined breast screening cost-effective over a range of incremental improvements in test performance.
The researchers found that the sensitivity, false-positive rate, and cancer detection rate of screening mammography increased with increasing numbers of radiologist work-ups for their own recalled mammograms.
Invisible tattoos preferable option to mark where a patient with breast cancer should receive radiotherapy during sessions.
What vaginal lubricants are available for for women with hormone-receptor positive (HR+) cancer?
For patients with schizophrenia and breast cancer, initial radical surgery without adjuvant radiation therapy may be preferred.
Pre-existing diabetes increases risk of total mortality among women with breast cancer.
A recent study has found a modest association between smoking and breast cancer risk in women.
When breast and colorectal cancers occur in children, the diseases are aggressive.
Generic aromatase inhibitors improved treatment adherence by 50% in hormone receptor-positive breast cancer.
Relaxation and yoga are the best complementary therapies for the treatment of breast cancer.
Recent trial investigated the impact of a yoga intervention on fatigue and inflammation among breast cancer survivors.
Children who underwent chest radiation for the treatment of Wilms tumor may have an increased risk for developing breast cancer.
Herceptin in addition to chemotherapy boosts survival, reduces risk of cancer recurrence
Findings in comparative economic analysis of patients with node-negative breast cancer showed the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making.
A change in diagnosis resulted from PET/CT imaging of patients who were younger than 40 years with an initial diagnosis of stage I-III breast cancer, according to a retrospective analysis.
'Extra Help' program allows more women of varying racial and ethnic backgrounds to continue their hormone therapy.
Patients with HER2-positive breast cancer that has metastasized demonstrate longer survival outcomes if treated with a combination of pertuzumab, trastuzumab, and chemotherapy.
A healthy lifestyle may improve survival of patients with breast cancer.
Women treated for breast cancer improved their quality of life after participating in post-treatment intervention.
Human epidermal growth factor receptor 2 (HER2) mutations may offer an important treatment target in a subset of patients with non-small cell lung cancer.
Breast cancer experts world-wide have urged for continued high quality research on advanced breast cancer.
Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) study confirms use of trastuzumab for HER2-positive breast cancer
The use of trastuzumab (Herceptin) as the standard-of-care treatment for HER2-positive breast cancer has been supported by the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) study.
Researchers have successfully tested a new tool that will help surgeons better distinguish cancerous breast tissue from normal tissue, which should lower the mount of repeat procedures needed.
Referrals for genetic counseling and testing for breast cancer risk more than doubled across the United Kingdom after Angelina Jolie's May 2013 announcement she tested positive for BRCA1 gene mutation and underwent a double mastectomy.
For patients with breast cancer, oral bisphosphonates may reduce risk for developing bone metastases
Oral bisphosphonates to treat osteoporosis may also slow skeletal metastases caused by breast cancer.
[Breast Cancer (Auckl)] Breast positioning is the key factor affecting a mammogram. Done properly, correct positioning maximizes the amount of breast tissue being imaged, eliminates most of the artifacts, and increases sensitivity of the mammogram.
Scientists are now developing an "electronic skin" that will aid in the detection of breast masses.
Exposure to dim light at night may make breast tumors resistant to chemotherapy
Despite its acceptance as standard of care neary 25 years ago, barriers still exist that preclude patients from receiving breast conserving therapy (BCT), according to research presented at the ASCO 2014 Breast Cancer Symposium.
Adding carboplatin and/or bevacizumab to the standard treatment regimen significantly improved pathologic complete response rates in patients with triple-negative breast cancer, according to a new phase 2 study.
Drug should remain standard of care for HER2-positive tumors, according to new research.
A recent study found no link between bra wearing and increased breast cancer risk among postmenopausal women.
An experimental regimen of once-weekly breast irradiation after lumpectomy provides more convenience to patients at less expense, and results in better completion rates of prescribed radiation treatment.
Is there a good reason to mix nab-paclitaxel (Abraxane) with warm (not cool) normal saline when reconstituting?
A new immunotherapy vaccine candidate for breast cancer shows promise, having reduced recurrence rate by more than fifty percent.
Women whose skirt size increases one size every 10 years have a 33% increased risk for developing breast cancer.
The experimental drug nintedanib, in combination with standard paclitaxel chemotherapy, caused a total remission of tumors in half of patients with early stage HER2-negative breast cancer.
Most women who chose to undergo double mastectomies despite having cancer in only one breast are content with their choice.
Mammograms for those aged 69 to 75 could result in over-treatment, researchers caution.
Scientists have developed a tool to distinguish each breast cancer subtype, research that could improve treatments and targeting of treatments for the disease.
Breast cancer cells can lay the groundwork for their own metastasis throughout the body by coaxing cells within lymphatic vessels to send out tumor-welcoming signals.
The BluePrint genomic test provides more accurate information about the molecular subtype of a specific breast cancer, compared with the use of conventional IHC-FISH pathology tests, according to a new study.
One-third of women who are given information about the potential for over-diagnosis through the National Health Services (NHS) breast screening program may not completely understand the risks involved.
Screening women for breast cancer up to age 75 may lead to overdiagnosis and overtreatment.
Postmenopausal women with a diverse gut microbiome have higher levels of estrogen metabolites.
The percentage of women that underwent a double mastectomy increased substantially between 1998 and 2011, even though the procedure was not associated with a lower risk of death than breast-conserving surgery plus radiation.
Women with severe disabilities and multiple chronic conditions are screened for breast cancer less often than women with no disabilities or no chronic conditions.
GP2, a novel immunotherapy, has demonstrated a reduction in recurrence in patients with breast cancer.
Integrated approach to pinpoint genetic drivers of cancer uncovers viable targets for breast cancer therapy
Researchers have developed a new integrated approach to identify the genetic drivers of cancer, uncovering eight genes necessary for cell proliferation in breast cancer.
Study raises questions about the effect of soy's estrogen-like properties.
Women overdue for mammogram respond better to postcard plus reminder letter from family physician.
A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to new research.
Evidence-based recommendations have been developed for chemotherapy and targeted therapy for women with HER2-negative advanced breast cancer.
Celebrity story helped double rates of genetic testing in following six months at one cancer center.
Women with breast cancer who have a double mastectomy are at higher risk of certain complications than those who have a single mastectomy, though the overall complication rate associated with breast cancer surgery is small.
Wearing bras does not increase a woman's risk for developing breast cancer.
This fact sheet examines the potential pros and cons of surgery as a means to reduce breast cancer risk.
Following a mastectomy, less than 42% of women underwent breast reconstruction, and the factors associated with foregoing reconstruction included being black, being less educated, and being older.
Survey of women with breast cancer explores factors in the decision to remove a healthy breast as a measure to prevent breast cancer.
Bilateral mastectomy-linked mortality rates are up for women diagnosed with stage 0 to III breast cancer.
Despite an increase in double mastectomy for early-stage breast cancer, the procedure does not reduce the risk of mortality.
A biomarker strongly linked to basal-like breast cancer has been identified.
Black Women's Health Study (BWHS) shows exercise improves breast cancer risk for African American women
This recently published study found strong evidence linking physical exercise to a lower rate of breast cancer in African American women, a group in which previous evidence has been lacking.
Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study.
Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study.
Postmenopausal women who in the past 4 years had undertaken regular physical activity equivalent to at least 4 hours of walking per week had a lower risk for invasive breast cancer compared with women who exercised less
The PALB2 gene is potentially one of the most important genes associated with breast cancer after the BRCA1/2 genes.
Recurrence of hormone-related breast cancer was reduced by 50% in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), according to newly published data.
Dasatinib shows promise for treating skin, breast and several other cancers.
MRI detects 18.1 additional cancers after negative findings with mammography and ultrasonography per 1,000 women.
Data from two randomized controlled trials suggest that bisphosphonate use does not protect against postmenopausal breast cancer, according to research.
In overweight women, aspirin or other drugs might make certain breast cancers more treatable.
Writing down fears, emotions, and the benefits of a cancer diagnosis may improve health outcomes for Asian American survivors of breast cancer, according to a new study. The research investigated methods of reducing the psychological burden among minority patients, particularly among breast cancer survivors.
New research suggests that cancer would be more accurately diagnosed in 1 of every 10 patients if their tumors were defined by cellular and molecular criteria rather than by the tissues in which they originated, and that this information, in turn, could lead to more appropriate treatments.
Mammography-detected breast cancer is associated with a shift to earlier stage diagnosis in older women, subsequently reducing the rate of more advanced, difficult-to-treat cases. Researchers said the findings lend support to regular mammography screening in women age 75 years and older.
Sign Up for Free e-newsletters
- Risk prediction improved by new classification in chronic lymphocytic leukemia
- Treatment options for HER2-positive breast cancer
- Antimicrobial agent triclosan, used in soaps and detergents, may cause cancer
- The Society for Integrative Oncology (SIO) and co-researchers issue a report card on complementary therapies for breast cancer
- Disparities in non-small cell lung cancer (NSCLC) treatment based on race, treatment center
- A New Era is Coming up in the Treatment of Chronic Lymphocytic Leukemia
- Early palliative care can cut hospital readmissions for cancer patients
- ONA Interview: Breaking the barriers to effective palliative care
- Fluorescent tattoos may improve self-esteem in patients receiving radiotherapy for breast cancer
- Cancer prehabilitation: One step toward improved outcomes
- Radiation exposure linked to aggressive thyroid cancers
- More patients opt for mastectomy despite limited, early-stage breast cancer
- Calcium channel blockers not found to increase risk of breast cancer
- Being overweight or obese may hide true nutritional status of patients with cancer
- Monitoring psychosocial function in radiotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|